Austin, TX, United States of America

Allyson Lebas

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bioo Scientific Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Allyson Lebas. Retrieved from https://idiyas.com/inventor/allyson-lebas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Allyson Lebas and Patent Work in Biotechnology

Introduction

Allyson Lebas is an inventor associated with Austin, Texas, and Bioo Scientific Corporation. The available information credits Lebas with 1 patent related to methods, compositions, and kits for inhibiting the formation of adapter dimers.

Latest Patents

Lebas is named on the patent “Methods, Compositions, and Kits for Inhibiting Formation of Adapter Dimers.” The invention concerns approaches for reducing adapter-dimer formation, a challenge relevant to preparing samples for molecular biology and sequencing workflows.

Career Highlights

Lebas’s listed patent work is connected with Bioo Scientific Corporation, a company focused on life-science products and technologies. The patent reflects work addressing a practical issue in preparing biological samples.

Collaborations

Kerry Gunning is identified as a coworker associated with Lebas. The available details do not specify her role in the patent or the nature of their collaboration.

Conclusion

Allyson Lebas’s recorded invention focuses on inhibiting adapter-dimer formation, linking her patent work with Bioo Scientific Corporation and biotechnology applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…